Cargando…

Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations

BACKGROUND: Androgen deprivation therapy (ADT) is foundational in the management of advanced prostate cancer (PCa) and has benefitted from a recent explosion in scientific advances. These include approval of new therapies that suppress testosterone (T) levels or inactivate its function, improvements...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crawford, E. David, Heidenreich, Axel, Lawrentschuk, Nathan, Tombal, Bertrand, Pompeo, Antonio C. L., Mendoza-Valdes, Arturo, Miller, Kurt, Debruyne, Frans M. J., Klotz, Laurence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370592/ https://www.ncbi.nlm.nih.gov/pubmed/30131604 http://dx.doi.org/10.1038/s41391-018-0079-0

Ejemplares similares

Active Surveillance for Favorable-Risk Prostate Cancer: A Short Review
por: Lawrentschuk, Nathan, et al.
Publicado: (2010)

Realistic Anatomical Prostate Models for Surgical Skills Workshops Using Ballistic Gelatin for Nerve-Sparing Radical Prostatectomy and Fruit for Simple Prostatectomy
por: Lawrentschuk, Nathan, et al.
Publicado: (2011)

Reporting and ideal testosterone levels in men undergoing androgen deprivation for prostate cancer—time for a rethink?
por: Cabarkapa, Sonja, et al.
Publicado: (2018)

Australian patterns of prostate cancer care: Are they evolving?
por: Lo, Jonathon, et al.
Publicado: (2016)

Anatomic Considerations for Radical Retropubic Prostatectomy in an Achondroplastic Dwarf
por: Gyomber, Dennis, et al.
Publicado: (2009)

Dietary interventions to improve body composition in men treated with androgen deprivation therapy for prostate cancer: a solution for the growing problem?
por: Umlauff, Lisa, et al.
Publicado: (2021)

Scoping review: hotspots for COVID-19 urological research: what is being published and from where?
por: Qu, Liang G., et al.
Publicado: (2020)

Trends in percutaneous renal biopsy: The evolving diagnostic pathway for the small renal mass
por: Perera, Marlon, et al.
Publicado: (2018)

Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations
por: Paolella, Gennaro A., et al.
Publicado: (2018)

Statin Use and Survival Among Men Receiving Androgen-Ablative Therapies for Advanced Prostate Cancer: A Systematic Review and Meta-analysis
por: Jayalath, Viranda H., et al.
Publicado: (2022)

Cytoreductive surgery for men with metastatic prostate cancer
por: Katelaris, Nikolas, et al.
Publicado: (2016)

Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation
por: Wex, Jaro, et al.
Publicado: (2013)

Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19
por: Sean Ong, Xuan Rui, et al.
Publicado: (2020)

Evolving perspectives of the role of novel agents in androgen-independent prostate cancer
por: Kalmadi, Sujith, et al.
Publicado: (2008)

Towards understanding androgen receptor-independent prostate cancer: an evolving paradigm
por: Zhou, Jianfu, et al.
Publicado: (2020)

Androgen deficiency and metabolic syndrome in men
por: Winter, Ashley G., et al.
Publicado: (2014)

Clinical Considerations for the Management of Androgen Indifferent Prostate Cancer
por: Berchuck, Jacob E., et al.
Publicado: (2021)

AB69. Phyto-androgenic androgens in men’s health, sex and aging FX
por: Adimoelja, Arif, et al.
Publicado: (2014)

Incidental prostate cancer in transurethral resection of prostate specimens in men aged up to 65 years
por: Perera, Marlon, et al.
Publicado: (2016)

Tissue Engineering and Regenerative Medicine: Semantic Considerations for an Evolving Paradigm
por: Katari, Ravi, et al.
Publicado: (2015)

Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy
por: Mocanu, Victor, et al.
Publicado: (2022)

Androgen-Regulated Cardiac Metabolism in Aging Men
por: Barrientos, Genaro, et al.
Publicado: (2020)

Men´s experiences of using anabolic androgenic steroids
por: Börjesson, Annica, et al.
Publicado: (2021)

Androgens In Men Study (AIMS): protocol for meta-analyses of individual participant data investigating associations of androgens with health outcomes in men
por: Yeap, Bu Beng, et al.
Publicado: (2020)

C++ evolves!
por: Naumann, Axel
Publicado: (2014)

Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?
por: Tombal, Bertrand, et al.
Publicado: (2012)

Generational analysis of trends in unprotected sex in France among men who have sex with men: The major role of context-driven evolving patterns
por: Méthy, Nicolas, et al.
Publicado: (2017)

Serum Levels of Androgen-Associated Hormones Are Correlated with Curative Effect in Androgenic Alopecia in Young Men
por: Zhang, Yingchun, et al.
Publicado: (2018)

Survival outcomes of younger men (< 55 years) undergoing radical prostatectomy
por: Tan, Lynn, et al.
Publicado: (2018)

Practical, ethical and regulatory considerations for the evolving medical and research genomics landscape()
por: Lyon, Gholson J., et al.
Publicado: (2013)

Where Are You Going, Nephrology? Considerations on Models of Care in an Evolving Discipline
por: Piccoli, Giorgina Barbara, et al.
Publicado: (2018)

Parameter Identifiability and Redundancy: Theoretical Considerations
por: Little, Mark P., et al.
Publicado: (2010)

SAT-010 Adrenal Androgen Synthesis in Aging Men
por: Namba, Aya, et al.
Publicado: (2019)

An Updated Review: Androgens and Cognitive Impairment in Older Men
por: Cai, Zhonglin, et al.
Publicado: (2020)

Factors Influencing Depression in Korean Men with Androgenic Alopecia
por: KIM, Jung-Won
Publicado: (2021)

Reliability of Drug History to Verify Androgen Abuse in Men
por: Shankara-Narayana, Nandini, et al.
Publicado: (2022)

Chemoprevention of prostate cancer with nutrients and supplements
por: Van Poppel, Hendrik, et al.
Publicado: (2011)

Cardiovascular risk during hormonal treatment in patients with prostate cancer
por: Van Poppel, Hein, et al.
Publicado: (2011)

Chronic IL-1 exposure drives LNCaP cells to evolve androgen and AR independence
por: Dahl, Haley C., et al.
Publicado: (2020)

Active surveillance versus nonradical treatment for low-risk men with prostate cancer: a review
por: Perera, Sachin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3fr1h2rj4idif9jf3ep4q9p083